Classification of Parkinson's disease with and without dopaminergic deficiency based on non-motor symptoms and structural neuroimaging
- PMID: 39969749
- DOI: 10.1007/s10072-025-08045-6
Classification of Parkinson's disease with and without dopaminergic deficiency based on non-motor symptoms and structural neuroimaging
Abstract
The presence of non-motor symptoms (NMS) such as olfactive deficit or neuropsychiatric symptoms has been associated with the diagnosis of Parkinson's Disease (PD). NMS are also associated with different brain structural features underlying distinctive processes in PD. NMS has been poorly studied in patients with a PD-like clinical profile, showing Scans Without Evidence of Dopaminergic Deficit (SWEDD). This study proposes to compare classification models differentiating PD, SWEDD and Healthy Controls (HC) based on NMS and neurostructural factors. 683 participants (382 PD diagnosed in the last 2 years, 48 with SWEDD, 170 HC) from the PPMI dataset were compared based on available assessments. Each participant underwent an olfactive, neuropsychiatric and sleep assessment, and a 3T MRI. Brain volumes were extracted and standardized from each MRI. Classifications were based on logistic regressions using 5-fold cross-validation models combining different NMS and MRI data and determining their involvement in differentiation between patient subgroups (PD vs. SWEDD) or between patients and HC. NMS were significant factors in PD vs. SWEDD, PD vs. HC and SWEDD vs. HC classifiers, when considered alone or in combination with MRI data. No classification models were significantly different from chance based-on MRI, nor more accurate combining NMS and MRI when compared with models based on NMS only. These results highlight the importance of NMS in differentiating between PD and SWEDD, PD and HC, SWEDD and HC. However, classical imaging data such as cortical and subcortical volumetry seems insufficient to improve these classifications. Other imaging features such as connectivity could also be studied.
Keywords: Classification model; MRI; Non-motor symptoms; Parkinson’s disease; SWEDD.
© 2025. Fondazione Società Italiana di Neurologia.
Conflict of interest statement
Declarations. Ethical approval and Informed consent statement: PPMI is a large multicenter study and each site independently received ethics approval of the protocol. All subjects gave written informed consent in accordance with the Declaration of Helsinki. See Marek et al. (2011) and the online PPMI protocol for details of the PPMI study and image acquisition, respectively. Ethics committee approval and individual patient consents were received by the PPMI (https://www.ppmi-info.org/study-design/research-documents-and-sops). The present study was approved by the Comité d’éthique de la recherche vieillissement-neuroimagerie CER VN 19-20-06. Competing interests: The author declares that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Similar articles
-
Explainable machine learning with pairwise interactions for the classification of Parkinson's disease and SWEDD from clinical and imaging features.Brain Imaging Behav. 2022 Oct;16(5):2188-2198. doi: 10.1007/s11682-022-00688-9. Epub 2022 May 26. Brain Imaging Behav. 2022. PMID: 35614327 Free PMC article.
-
Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function.J Parkinsons Dis. 2016 Oct 19;6(4):771-778. doi: 10.3233/JPD-160874. J Parkinsons Dis. 2016. PMID: 27567887
-
Distinctive clinical and imaging trajectories in SWEDD and Parkinson's disease patients.Neuroimage Clin. 2024;42:103592. doi: 10.1016/j.nicl.2024.103592. Epub 2024 Mar 14. Neuroimage Clin. 2024. PMID: 38493585 Free PMC article.
-
Non motor subtypes and Parkinson's disease.Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S41-6. doi: 10.1016/j.parkreldis.2015.09.027. Epub 2015 Sep 11. Parkinsonism Relat Disord. 2016. PMID: 26459660 Review.
-
The challenge of non-motor symptoms in Parkinson's disease.Prog Brain Res. 2010;184:325-41. doi: 10.1016/S0079-6123(10)84017-8. Prog Brain Res. 2010. PMID: 20887883 Review.
References
-
- Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601. https://doi.org/10.1002/mds.26424 - DOI - PubMed
-
- Macías-García P, Rashid-López R, Cruz-Gómez ÁJ et al (2022) Neuropsychiatric symptoms in clinically defined Parkinson’s Disease: an updated review of literature. Behav Neurol 2022:1213393. https://doi.org/10.1155/2022/1213393 - DOI - PubMed - PMC
-
- Aarsland D, Kramberger MG (2015) Neuropsychiatric symptoms in Parkinson’s Disease. J Park Dis 5:659–667. https://doi.org/10.3233/JPD-150604 - DOI
-
- Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435–450. https://doi.org/10.1038/nrn.2017.62 - DOI - PubMed
-
- Xiao Q, Chen S, Le W (2014) Hyposmia: a possible biomarker of Parkinson’s disease. Neurosci Bull 30:134–140. https://doi.org/10.1007/s12264-013-1390-3 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical